← Back to patent-cliff list
CAS 1094797-87-1
1-(3-aminophenyl)-N-(2-(dimethylamino)ethyl)methanesulfonamide
Codes: SULFA-004
Application context (from source-drug indications)
Neuroendocrine tumourSurufatinibPancreatic cancerSurufatinibNeuroendocrine carcinomaSurufatinibPancreatic neuroendocrine tumourSurufatinibIntestinal neoplasmSurufatinib阑尾肿瘤Surufatinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Surufatinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-methyl-1H-indol-5-ol→2,4-dichloropyrimidine→5-((2-chloropyrimidin-4-yl)oxy)-2-methyl-1H-indole→1-(3-aminophenyl)-N-(2-(dimethylamino)ethyl)methanesulfonamide→Sulfatinib
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.